Unlock stock picks and a broker-level newsfeed that powers Wall Street.
IOB - Delayed Quote EUR

Carl Zeiss Meditec AG (0DHC.IL)

Compare
48.61
-4.04
(-7.67%)
At close: April 4 at 6:57:25 PM GMT+1
Loading Chart for 0DHC.IL
  • Previous Close 52.65
  • Open 51.50
  • Bid 47.40 x --
  • Ask 49.92 x --
  • Day's Range 47.18 - 52.20
  • 52 Week Range 44.28 - 107.90
  • Volume 67,872
  • Avg. Volume 29,491
  • Market Cap (intraday) 4.635B
  • Beta (5Y Monthly) 0.90
  • PE Ratio (TTM) 14.21
  • EPS (TTM) 3.42
  • Earnings Date May 14, 2025
  • Forward Dividend & Yield 1.10 (1.42%)
  • Ex-Dividend Date Mar 23, 2023
  • 1y Target Est --

Carl Zeiss Meditec AG operates as a medical technology company in Germany, rest of Europe, the United States, Asia, and internationally. It operates in two segments, Ophthalmic Devices and Microsurgery. The Ophthalmic Devices segment offers offers products and solutions for the diagnosis and treatment of chronic eye diseases; and systems and consumables for refractive surgery. This segment also provides slit lamps, refractometers, tonometers, optical coherence tomography devices, and fundus cameras used for the examination of the retina in hospitals and practices; and equipment for functional diagnostics. In addition, this segment offers surgical microscopes, biometers, and phacoemulsification or vitrectomy devices; and intraocular lenses for cataract patients. The Microsurgery segment offers visualization solutions for invasive surgical treatments; and solutions in the area of ear, nose and throat, plastic and reconstructive, neuro, dental, and spinal surgeries. It serves physicians in various fields and hospitals. The company was founded in 1846 and is headquartered in Jena, Germany. Carl Zeiss Meditec AG is a subsidiary of Carl Zeiss AG.

www.zeiss.de/meditec-ag/home.html

4,224

Full Time Employees

September 30

Fiscal Year Ends

Recent News: 0DHC.IL

View More

Performance Overview: 0DHC.IL

Trailing total returns as of 4/4/2025, which may include dividends or other distributions. Benchmark is DAX P (^GDAXI) .

YTD Return

0DHC.IL
6.03%
DAX P (^GDAXI)
3.68%

1-Year Return

0DHC.IL
55.42%
DAX P (^GDAXI)
12.16%

3-Year Return

0DHC.IL
67.02%
DAX P (^GDAXI)
42.18%

5-Year Return

0DHC.IL
40.32%
DAX P (^GDAXI)
116.69%

Compare To: 0DHC.IL

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: 0DHC.IL

View More

Valuation Measures

Annual
As of 4/4/2025
  • Market Cap

    4.27B

  • Enterprise Value

    4.40B

  • Trailing P/E

    24.18

  • Forward P/E

    25.06

  • PEG Ratio (5yr expected)

    1.20

  • Price/Sales (ttm)

    2.09

  • Price/Book (mrq)

    2.08

  • Enterprise Value/Revenue

    2.13

  • Enterprise Value/EBITDA

    10.91

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    14.81%

  • Return on Assets (ttm)

    --

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    2.08B

  • Net Income Avi to Common (ttm)

    307.91M

  • Diluted EPS (ttm)

    3.42

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    12.36M

  • Total Debt/Equity (mrq)

    7.92%

  • Levered Free Cash Flow (ttm)

    --

Research Analysis: 0DHC.IL

View More

Company Insights: 0DHC.IL

Research Reports: 0DHC.IL

View More

People Also Watch